The history of the Smedvig family’s operations demonstrates an excellent track record in managing businesses.
The history of the Smedvig family’s operations demonstrates an excellent track record in managing businesses. The Smedvig Family Office aims to build and operate a robust and well performing investment portfolio. The objective is to secure and grow the wealth of current and future generations of the Smedvig family; hence the time-horizon for the investments is long.The portfolio is focussed on capital growth, while at the same time optimizing risk to avoid permanent loss of capital and ensuring long term capital preservation. Total assets under management are approximately NOK 10 billion.The Smedvig family invests across a wide range of asset classes and has considerable experience in successfully investing in the natural resources sector globally. The Smedvig Family Office makes direct investments as a lead investor within property, private equity and episodic/thematic investments, and invests with best of breed managers of private equity-, long only-, and hedge funds.In addition, [Smedvig Capital](http://www.crunchbase.com/financial-organization/smedvig-capital) was established in London in 1996 to handle the company’s venture capital and private equity investments.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 3, 2021
Amyl Therapeutics
|
Series A | €8.60M | Biotechnology | — |